Two-thirds of Britons with common life-threatening conditions have been denied care during pandemic
June 8, 2020Sales and Marketing COVID, COVID-19, NHS, NHS England, coronavirus, pandemic
Nearly two-thirds of people in Britain have been denied care for common life-threatening conditions by the NHS, due to their …
US supply of Gilead’s remdesivir expected to run out by the end of June
June 8, 2020Sales and Marketing
The US government will run out of their current supply of Gilead’s remdsivir by the end of the month, the …
Oxford Biomedica joins forces with UK’s Vaccines Manufacturing and Innovation Centre to scale up production of Oxford Uni’s COVID-19 vaccine
June 8, 2020Manufacturing and Production, Sales and Marketing COVID-19, Oxford BioMedica, University of Oxford, Vaccine, coronavirus, pharma
Oxford Biomedica has forged a five-year partnership with the Vaccines Manufacturing and Innovation Centre (VMIC) to work together to provide …
Coronavirus pandemic puts UK’s post-Brexit drug stockpile at risk
June 8, 2020Sales and Marketing COVID-19, coronavirus, drugs
The pharmaceutical industry has warned the UK government that certain stockpiles of medicine have been used up due to the …
Stacey Coen appointed Senior Vice President and Chief Business Officer at ImmunoGen
June 5, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
ImmunoGen have appointed Stacey Coen as their new Senior Vice President and Chief Business Officer. She joins the company from …
Australian Taskforce recommends Gilead’s remdesivir for routine use in the country’s COVID-19 patients
June 5, 2020Medical Communications, Sales and Marketing Australia, COVID-19, Gilead, coronavirus, remdesivir
Australia could be set to follow the decisions of other nations around the world in officially licensing Gilead’s antiviral therapy …
British COVID-19 test-and-trace system will not be fully operational until September, despite it launching last month
June 5, 2020Medical Communications COVID-19, NHS, coronavirus
The NHS COVID-19 test-and-trace system will not be fully operational until September or October, leaked emails from personnel involved with …
The Lancet retracts paper that highlighted the dangers of taking hydroxychloroquine
June 5, 2020Medical Communications COVID-19, Lancet, hydroxychloroquine
The Lancet has retracted a paper that claimed to show that people who took hydroxychloroquine to treat COVID-19 had a …
AstraZeneca announces new partnerships to deliver two billion COVID-19 vaccine doses, with focus on developing countries
June 5, 2020Manufacturing and Production, Medical Communications AstraZeneca, COVID-19, Vaccine, coronavirus
As efforts to make an effective vaccine against COVID-19 available around the world continue to gather pace, AstraZeneca has revealed …
Top Ten most popular articles on Pharmafile.com this week
June 5, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus
This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for …
Novartis’ Cosentyx hits primary goal in Phase 3 non-radiographic axial spondyloarthritis study
June 4, 2020Research and Development Cosentyx, Novartis, axial spondyloarthritis
New Phase 3 data has been released on the efficacy of Novartis’ interleukin (IL)-17A inhibitor Cosentyx (secukinumab), showing that the …
Trump’s Operation Warp Speed selects Pfizer, Merck, AstraZeneca and Moderna as vaccine finalists
June 4, 2020Business Services COVID-19, Operation Warp Speed, Trump, coronavirus
The Trump administration has selected the finalists for the COVID-19 vaccine it is seeking to make widely available by the …
Janssen’s Tremfya shows skin clearance benefit for psoriatic arthritis patients in two Phase 3 studies
June 4, 2020Research and Development Janssen, Tremfya, psoriatic arthritis
Janssen has revealed data from two Phase 3 trials for Tremfya (guselkumab), showing improvement in skin clearance and symptoms in …
Fitbit’s Flow ventilator receives FDA emergency approval
June 4, 2020Business Services COVID-19, coronavirus, ventalitor
The FDA has granted emergency approval for Fitbit’s ‘Fitbit Flow’ ventilator, a low cost piece of equipment to help fight …
Hydroxychloroquine does not work as a preventative against COVID-19, new study finds
June 4, 2020Business Services COVID-19, coronavirus, hydroxychloroquine
The malaria drug hydroxychloroquine does not protect people from COVID-19, according to a new study led by researchers at the …
India and South Korea approve Gilead’s remdesivir for emergency use against COVID-19
June 3, 2020Research and Development, Sales and Marketing COVID-19, Gilead, India, coronavirus, remdesivir, south korea
India and South Korea have moved to follow in the footsteps of the US in approving Gilead’s antiviral therapy remdesivir …
Lancet expresses concern over published hydroxychloroquine and chloroquine paper
June 3, 2020Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine
The Lancet’s editors have expressed their concerns over a paper published in their journal that said hydroxychloroquine and chloroquine was …
The Association of American Physicians & Surgeons sue FDA to end restrictions on hydroxychloroquine, despite evidence it can be life threatening
June 3, 2020Research and Development AAPS, COVID-19, coronaviryus
The Association of American Physicians & Surgeons have filed a lawsuit against the FDA due to it blocking widespread access …
Kings College London launches trial investigating the effectiveness of ibuprofen in COVID-19 patients
June 3, 2020Research and Development COVID-19, coronavirus, ibuprofen
Kings College London has launched a clinical trial to investigate how effective a formulation of ibuoprofen is in reducing respiratory …
Pharmafile.com’s weekly COVID-19 news round-up
June 3, 2020Research and Development COVID-19, coronavirus
COVID-19 treatments dominate the news this week as Russia is set to start its roll out of the anti-viral drug …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
